Innovating Works
HAIKU: A breakthrough alternative to antibiotics for preventing and curing infectious diseases at Intensive... REMAB THERAPEUTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Hospital-acquired infections are a major cause of morbidity, mortality and costs in Intensive care units (ICUs) worldwide. The most critical...
2019-02-05 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.